Purchase of drug with active substance alteplase

This tender for Alteplase is a straightforward procurement with a single evaluation criterion: price. Success hinges on meticulous adherence to all submission requirements and offering the most competitive price while ensuring full compliance with technical and legal specifications. Focus on cost efficiency and streamlined submission processes.

Most Cost-Effective Compliant Solution

Guaranteed Availability and Quality

Seamless and Error-Free Submission

Achieve the lowest possible price while ensuring profitability. This requires a deep understanding of your cost structure and potential for economies of scale. Leverage any existing supply agreements or bulk purchasing power.

Achieve 100% compliance. Any non-compliance will lead to disqualification, rendering price irrelevant. Meticulously review all requirements and ensure all documentation is accurate, complete, and submitted in the correct format and by the deadline.

Ensure Vorm 4 is filled out with absolute precision. Double-check drug name, manufacturer, unit price, and total offer cost. Any discrepancy can lead to disqualification. Verify calculations meticulously.

Since price is the sole evaluation criterion, conduct thorough cost analysis to determine the lowest viable price that ensures profitability. Explore all cost-saving measures in procurement, logistics, and operations.

Scrutinize Hankepass täiendatavate selgitustega and all related documents for exclusion grounds and eligibility requirements. Ensure all declarations are accurate and all supporting documents (licenses, permits) are valid and submitted.

Form a small, dedicated team to review the entire bid package before submission. This team should include individuals familiar with procurement processes and the specific tender requirements to catch any errors.

Confirm that the offered Alteplase drug precisely matches the specifications in 'HAD Lisa 1 - Tehniline kirjeldus.docx' regarding dose, pharmaceutical form, and quantity. Any deviation can lead to disqualification.

Before starting the bid preparation, ensure all required licenses, permits, and compliance documents are current and readily available. Do not wait until the last minute to discover an expired document.

If considering a joint bid, thoroughly understand and correctly complete 'Vorm 3_Volitus_ühispakkujad.doc', clearly defining responsibilities and authorizations.

This tender for alteplase medicine procurement is well-structured, clear, and fair, demonstrating strong legal compliance and data consistency. Its primary area for improvement lies in the integration of sustainability criteria.

The tender appears to adhere to standard legal requirements, with reasonable deadlines, clear procedure type, correct CPV codes, and no reported disputes. The use of ESPD indicates compliance with EU/national regulations.

The description is clear, requirements are well-structured and documented, and evaluation criteria are explicitly defined as 100% price-based. AI-extracted requirements are comprehensive and understandable.

All essential information, including basic details, financial data, timeline, classification, and detailed requirements, is provided and supported by 11 attached documents.

The tender demonstrates high fairness with full document access, disclosed value, reasonable deadlines, objective price-based evaluation, and e-procurement enablement. Requirements do not appear tailored to a specific company.

Electronic submission is supported, and duration is clear. The absence of an explicit contract start date is a minor point, but the overall practicality is good.

All key fields are populated, and dates are logical and consistent. There are no reported suspensions or disputes, indicating high data integrity.

The tender lacks any explicit green, social, or innovation criteria, which is common for this type of procurement but results in a low score for this specific category.